Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
Akhil Santhosh, Consultant Medical Oncologist at Baby Memorial Hospitals, shared a post on X about a recent article by Claire N. Harrison et al., published in JCO Oncology Advances, adding:
“Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study, JCO Oncology Advances.”
Title: Efficacy and Safety Outcomes With Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia: Analysis of Data From the Phase III PERSIST-2 Study
Authors: Claire N. Harrison, Prithviraj Bose, Ruben Mesa, Aaron T. Gerds, Stephen T. Oh, Marta Sobas, Valentín Garcia-Gutierrez, Christof Scheid, Alessandro Maria Vannucchi, Jean-Jacques Kiladjian, Vikas Gupta, Abdulraheem Yacoub, David Lavie, Purvi Suthar, Karisse Roman-Torres, Sarah A. Buckley, John Mascarenhas
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI